We conducted a retrospective analysis of all bile specimens obtained for routine cultures from January 1995 through December 1999 at our tertiary care hospital. Results of microbiologic testing were linked to clinical parameters gathered by means of chart review. A total of 722 isolates were cultured from 345 of 454 bile specimens obtained from 288 individual patients. Prior receipt of a 17-day course of antibiotics (odds ratio [OR], 5.7), extensive leukocytosis (leukocyte count, 120,000 cells/mL) on admission (OR, 7.8), endoscopic or percutaneous biliary manipulation during the previous 14 days (OR, 2.9), and treatment in an internal medicine ward (OR, 2.5) were independent factors significantly associated ( ) with recovery of Candida species from bile P р .05 specimens. Culture of mezlocillin-resistant bacteria from bile specimens was independently associated with the specimen having been obtained 11 week after admission (OR, 3.8), lack of history of endoscopic biliary drainage (OR, 3.2), and high serum aspartate aminotransferase levels (172 U/L) on admission (OR, 2.6). Prospective studies are warranted to evaluate accordingly adjusted empiric therapies for biliary infections.
Biliary infections are associated with high rates of morbidity and mortality. Despite the availability of powerful broad-spectrum antibiotics, the management of cholangitis remains a great challenge for the clinician [1] [2] [3] . The now commonly used nonoperative procedures, such as endoscopic retrograde cholangiopancreaticography (ERCP) and percutaneous transhepatic cholangiography or drainage (PTCD), have led to an increasing number of bile specimens being sent routinely to laboratories for microbiologic evaluation. Although the bile of healthy persons is considered to be sterile, varying degrees of bacterbilia (i.e., bacteria growing from bile) were noted in studies that evaluated patients without apparent clinical signs or laboratory evidence of cholangitis or cholecystitis [1] . Therefore, it remains difficult to interpret the findings for bile specimens obtained through endoscopic, radiologic, or operative procedures. Although several studies have sought to define the spectra of isolated pathogens and their susceptibility to antibiotics, recent data that reflect the continuing increase of resistance to antimicrobial compounds and clinical impact of biliary fungal isolates are scarce [1, [3] [4] [5] [6] . We conducted the present study to describe the current spectrum of pathogens cultivated from bile specimens at a tertiary care hospital and to identify clinical settings associated with the growth of pathogens that are resistant to antibiotics commonly used for empiric treatment of biliary infections.
MATERIALS AND METHODS
We conducted a retrospective analysis of all routine cultures of bile specimens obtained from 1 January 1995 Table 1 . Distribution of species for the 722 isolates cultured from bile specimens at Regensburg University Hospital, a tertiary care hospital, compared with the results of selected studies published elsewhere.
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through 31 December 1999 at our tertiary care hospital. Native specimens were centrifuged, and the resulting bile sediments were subjected to Gram staining and culturing on solid media, which included chocolate, Columbia, MacConkey, Sabouraud, and Schaedler agars. An aliquot was also inoculated into prereduced thioglycolate broth. Some of the specimens were sent to the laboratory already placed in commercially available BacT/ Alert blood culture bottles (Organon Teknika). We were not able to perform direct Gram staining on these specimens. In the analysis of susceptibility to antibiotics commonly used for treatment of biliary infection, we included the results for all isolates for which routine antibiotic susceptibility tests were performed. Species identification was done according to internationally established methods [7] . Antibiotic susceptibility testing was done by use of the disk-diffusion method, in accordance with the guidelines of the National Committee for Clinical Laboratory Standards [8] .
A chart review for clinical parameters was performed for all patients who had positive results of bile cultures. Data regarding demographic characteristics (age and sex) and symptoms at presentation (diagnosis, duration of symptoms prior to admission, and fever) were obtained. Also recorded were the following abnormal initial laboratory values: leukocyte count, 120,000 cells/mL; serum C-reactive protein, 1100 mg/L; serum total bilirubin, 14 mg/dL; serum alkaline phosphatase, 1680 IU/L; serum aspartate aminotransferase (sAST), 172 IU/L; and serum alanine aminotransferase, 188 IU/L (the latter 4 cutoff values represent 4 times the upper limit of the normal range). In addition, we noted any history of prior biliary tract manipulations (ERCP, PTCD, or operations of the biliary tract). Furthermore, prior or ongoing treatment with antibiotics or antacids was noted, as was the procedure used to obtain bile specimens. In the context of the present study, "cholangitis" was defined by the presence of fever (temperature, 138.0ЊC) or systemic signs of inflammation at presentation together with clinical or laboratory signs of biliary obstruction. "Malignoma" was defined as malignant disease that involved the biliary tract without fever or systemic signs of inflammation at initial presentation. These clinical parameters were correlated to the first positive bile culture result obtained for each individual patient. We analyzed the distribution of different pathogen types, and we evaluated the resistance profiles of pathogens to antibiotics commonly used for the treatment of biliary infections.
For the subset of isolates recovered from patients for whom clinical data were available from chart review, the results of microbiologic testing were correlated to clinical parameters regarding medical history and initial presentation. Clinical factors associated with the culture that yielded Candida species or bacteria resistant to mezlocillin (an antibiotic commonly used as empiric treatment of patients with biliary infections) were delineated in univariate analysis by use of the x 2 or Fisher's exact tests, where appropriate. Multiple logistic-regression models were created by stepwise-backward procedures to delineate independent factors associated with cultures that yielded Candida species or mezlocillin-resistant bacteria, and these models were evaluated for possible statistical interaction between factors. Statistical computations were performed by use of SigmaStat software (SSPS).
RESULTS
During the 5-year study period, 454 bile specimens obtained from 288 individual patients were sent to the microbiology laboratory at our institution. Of the 454 specimens sent to the microbiology laboratory at our institution, 345 (obtained from 215 patients) were culture positive, yielding 722 isolates; 172 culture-positive specimens (51%) yielded 11 pathogen. Of the culture-positive specimens, 227 (66%) yielded gram-positive bacteria, 207 (60%) yielded gram-negative bacteria, 107 (31%) yielded Candida species, and 19 (6%) yielded anaerobic bacteria. Escherichia coli, Klebsiella species, Enterobacter species, Pseudomonas aeruginosa, and Citrobacter freundii were the most frequently recovered gramnegative species. More than 50% of the isolated gram-positive bacteria were identified as enterococci, but coagulase-negative staphylococci and viridans group streptococci also were frequently noted. All but 1 of the fungal isolates were determined to be Candida species, the majority of which being Candida albicans. Most of the anaerobic isolates belonged to the genera Bacteroides or Clostridium. For 162 (22%) of 722 isolates, an isolate of the same species had been detected in a bile specimen previously obtained from the patient. Exclusion of these isolates or stratification by clinical diagnosis did not substantially alter the species distribution (data not shown), although lower prevalences of P. aeruginosa (1%) and Candida species (6%) were noted for isolates that were obtained from patients with cholecystitis. Table 1 summarizes the distribution of species and compares that distribution to data published elsewhere [5, 6, [9] [10] [11] [12] [13] [14] [15] [16] . a As opposed to a surgical ward. Table 2 shows a pooled analysis of the isolates' susceptibility to antibiotics commonly used to treat biliary infections. The data shown were derived from 556 isolates for which antibiotic susceptibility data was available of the overall 593 aerobic grampositive and aerobic gram-negative isolates. The susceptibility rates of gram-negative isolates for piperacillin-sulbactam, ciprofloxacin, ceftazidime, gentamicin, and imipenem were all 188%. Lower gram-negative susceptibility rates (range, 53%-79%) were noted for mezlocillin, piperacillin, amoxicillinclavulanic acid, cefuroxime, and ceftriaxone, which are commonly used for empiric treatment of biliary infections. Of the gram-positive isolates, 98% were susceptible to vancomycin. The gram-positive organisms had lower rates of susceptibility to amoxicillin-clavulanic acid, piperacillin, piperacillin-sulbactam, mezlocillin, and imipenem (range, 69%-77%). Most gram-positive isolates were resistant to cephalosporins, ciprofloxacin, and gentamicin, with susceptibility rates of !25%. Fifty-nine of 86 C. albicans isolates and 20 of 23 non-albicans Candida isolates were tested for susceptibility to miconazole, revealing rates of susceptibility to azoles of 100% and 90%, respectively.
Clinical data were available for 176 (82%) of 215 patients for whom bile cultures had positive results. Of these 176 patients, 106 (60%) were male, 105 (60%) had been treated in the internal medicine department (versus 71 [40%] who had been treated in surgical departments), and 116 (66%) were aged 160 years. A diagnosis of cholangitis was recorded for 67 patients (38%); cholecystitis, for 32 (18%); malignant disease causing biliary obstruction, without fever or signs of systemic inflammation on initial presentation, for 56 (32%); pancreatitis, for 9 (5%); and other diagnoses, for 12 (7%). Other clinical parameters for the 176 patients are listed in table 3.
The association of clinical parameters with the growth on culture of Candida species and mezlocillin-resistant bacteria in univariate and multivariate analysis is shown in table 4. There was no significant statistical interaction between the independent factors in each model. Prior treatment with a 17-day course of antibiotics (OR, 5.7), extensive leukocytosis (leukocyte count, 120,000 cells/mL) on admission (OR, 7.8), receipt of endoscopic or percutaneous biliary manipulation in the 14 previous days (OR, 2.9), and treatment in an internal medicine ward (OR, 2.5) were significant ( ) factors independently P р .05 associated with the recovery of Candida species from bile specimens. Bile culture that yielded mezlocillin-resistant bacteria was independently associated with a specimen having been obtained 11 week after admission (OR, 3.8), no history of ERCP (OR, 3.2), and high sAST levels (172 IU/L) on admission to the hospital (OR, 2.6).
DISCUSSION
We conducted the present study to describe a current spectrum of pathogens cultivated from bile specimens at a tertiary care hospital, and we set out to identify clinical settings associated with the growth of pathogens that are resistant to antibiotics commonly used for empiric treatment of biliary tract infections. A comparison of our results with data published elsewhere (table 1) reveals that, despite substantial changes in the practice of clinical medicine that have occurred during the past 30 years, the bacterial species being isolated from bile specimens remain the same [5, 6, [9] [10] [11] [12] [13] [14] [15] [16] . Overall, there was an increase in the incidence of enteric gram-negative species other than E. coli and Klebsiella species, as compared with previously published data [15] . The prevalence of P. aeruginosa isolates (5%) in our study was comparable to the prevalences reported elsewhere [5, 6, [9] [10] [11] [12] [13] [14] [15] [16] . In contrast to studies published elsewhere, the prevalence of gram-positive isolates (39%) in the present study was relatively high [5, 6, [9] [10] [11] [12] [13] [14] [15] [16] . Although gram-positive bacteria were noted in only 40% of the previously performed Gram stains, which indicates that some of these isolates may have been contaminants rather than pathogens, 66% of all bile cultures with positive results yielded gram-positive bacteria. In the absence of clear results from randomized trials evaluating the clinical impact of coverage for enterococci and coagulase-negative staphylococci, our results lead one to question the use of antibiotics, such as cephalosporins and quinolones, that have no or only marginal activity against these organisms.
The high prevalence of fungi among all isolated pathogens (15%), with Candida species recovered from approximately one-third of positive bile cultures, emphasizes the potential clinical relevance of these organisms. In contrast to the findings of most other studies, which have reported lower rates of isolation of Candida species from bile specimens, the high rates noted in our study and that of Khardori et al. [10] may be explained by the high prevalence of broad-spectrum antibacterial (pre-) treatment and immunosuppression in both study populations [5, 6, 9, 14] . If one takes into account the rarity of recovery of Candida species from the blood cultures of nonneutropenic patients, the low rate of Candida species-positive blood cultures for patients with biliary tract infections does not preclude the possibility that these organisms have an important pathogenetic role [9] . The relatively low prevalence of anaerobic bacteria may, in part, reflect suboptimal handling and shipping of bile specimens under routine conditions in our cohort. In a prospective study especially designed to optimize the recovery of anaerobic pathogens from bile specimens, anaerobic pathogens were noted in 152% of all culture-positive specimens [12] . However, the low rates of recovery in this and in other studies, and the low rates of anaerobic concomitant bacteremia after cholangitis in reports published elsewhere, lead one to question the clinical significance of these organisms in biliary disease [5, 9, 10] .
The susceptibility data for antibiotics commonly used for empiric treatment of cholangitis are shown in table 2 and reflect the distribution of the isolated species. Studies published elsewhere have not addressed or have evaluated only a small number or subsets of isolates for susceptibility to antibiotics [5, 6, 9, 10] . Although the qualitative distribution of species for gramnegative isolates was relatively similar to that reported elsewhere [5, 9, 13, 14] , a high rate of resistance to commonly used antibiotics was observed. Although the prevalence of mezlocillin-susceptibility was ∼99% in a randomized clinical trial published in 1989 [17] , only 63% of gram-negative isolates in the present study were susceptible to this compound. The high prevalence of resistance to cephalosporins, ciprofloxacin, and gentamicin among gram-positive isolates reflects the predominance of enterococci and coagulase-negative staphylococci. However, our study demonstrated a marked increase in the incidence of quinolone-resistant enterococcal isolates, as compared with a report from 1994 [9] . Thus far, the general incidence of vancomycin-resistant enterococci and vancomycinresistant coagulase-negative staphylococci has remained very low at our institution [18] , which is reflected by the excellent susceptibility of gram-positive bile pathogens to vancomycin in the present study. Only a ureidopenicillin combined with a b-lactamase inhibitor or imipenem yielded susceptibility rates of 180% for all bacterial isolates, which leads one to advocate empiric therapy with these antibiotics for patients with severe cholangitis; use of carbapenems is probably best saved for patients who have nosocomial infections and who have received prolonged prior antibiotic therapy or have undergone prior biliary instrumentation.
Clinical data gathered by chart review were correlated with microbiologic data to delineate the clinical factors associated with the recovery of pathogens not covered by commonly used antibiotics for empiric therapy of biliary infections. Multiple factors other than the isolated pathogens and the adequacy of antibiotic coverage contribute to the clinical outcome in biliary infections [1, 3, 19] . Because these factors (e.g., the degree of biliary decompression) could not be specified exactly for each patient in our retrospective analysis, an analysis of the association of isolated pathogens with the clinical outcome of patients was not performed.
Although theories regarding the pathogenetic role of fungal isolates in patients with cholangitis remain controversial, Diebel et al. [4] performed a retrospective analysis of 27 cases of gallbladder and biliary tract candidiasis and concluded that patients with candidal cholecystitis in intensive care units have a very poor prognosis [1, 3, 4, 17, 19] . Most authors do not recommend use of antifungal drugs for empiric therapy of cholangitis [1, 3, 17, 19] . Therefore, the knowledge of the clinical factors associated with isolation of Candida species from bile specimens could help target the use of antifungal agents in empiric therapy. In our cohort of 176 evaluable patients, prior treatment with a 17-day course of antibiotics, severe leukocytosis on admission, endoscopic or percutaneous manipulation of the biliary tract in the 14 previous days, and receipt of treatment in an internal medicine ward were significant factors associated independently with recovery of Candida species from a patient's first positive bile culture result. Although biliary infections with Candida species as single pathogen were not common in our series or in other series, the clear delineation of these associations argues against the hypothesis that the isolation of Candida species should generally be considered the result of contamination. In the absence of randomized clinical trials that have evaluated the use of empiric antifungal therapy, the exact impact of Candida species isolated from bile specimens remains unclear.
Ureidopenicillins (e.g., mezlocillin, piperacillin) have a broad antibacterial spectrum and achieve high concentrations in bile specimens, and results of clinical trials reported elsewhere have been promising, which suggests that they can be used for empiric treatment of cholangitis [1, 3, 17, 19] . At our institution, mezlocillin with or without metronidazole was considered the first choice for empiric therapy for patients with biliary infections during the study period. The high rates of drug-resistance in our study and in another study [6] , however, lead one to question this practice. Clinical factors associated with the recovery of mezlocillin-resistant bacteria from the first positive bile culture included cultures of samples obtained after the seventh day of hospitalization and a very high sAST level. This suggests that mezlocillin resistance is associated with nosocomial infection and/or with very sick patients. Female patients were also more likely to harbor drug-resistant pathogens. The unexpected finding that patients who had not previously undergone endoscopic biliary drainage were at a higher risk for acquiring infections with mezlocillin-resistant bacteria is not likely to have a direct mechanistic cause. Rather, this association may indicate that lack of a history of ERCP serves as a surrogate marker for a factor not included in our analysis-for instance, the specific pretreatment of patients with ureidopenicillins.
In conclusion, this retrospective analysis demonstrated an increasing rate of isolation of enteric gram-negative bacteria (other than E. coli and Klebsiella species) from bile specimens and increasing rates of bacterial resistance to antibiotics commonly used for empiric therapy, such as the ureidopenicillins. The present results are based on retrospective data. However, the delineation of clinical factors associated with isolation of Candida species and mezlocillin-resistant bacteria should caution clinicians to use ureidopenicillins without concomitant use of b-lactamase inhibitors for heavily pretreated and/or severely ill patients with biliary infections and advocate the empiric use of antifungal agents in appropriate clinical settings. A prospective evaluation of such risk-adjusted approaches is warranted.
